Can viral load, semi-quantitatively evaluated, of human papillomavirus predict cytological or histological outcome in women with atypical squamous or glandular cells of undetermined significance cytology?

European Journal of Gynaecological Oncology

Volumn 26, Issue 4, 2005, Pages 393-397

  Wensveen, C W M ^a,b,c   Kagie, M J ^a   Nagelkerke, N J D ^b   Veldhuizen, R W ^a   Trimbos, J B M Z ^b  

^a MEDICAL CENTER HAAGLANDEN   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Atypical glandular cells of undetermined significance; Atypical squamous cells of undetermined significance; Cervical intraepithelial neoplasia; Human papillomavirus; Viral load

Indexed keywords

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PAPANICOLAOU TEST; SQUAMOUS CELL; SQUAMOUS CELL CARCINOMA; UTERINE CERVICITIS; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS EXAMINATION; VIRUS INFECTION; VIRUS LOAD; WART VIRUS;

ADOLESCENT; ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; REMISSION, SPONTANEOUS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 23744471082     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Manos M.M., Kinney W.K., Hurley L.B., Sherman M.E., Shieh-Ngai J., Kurman R.J. et al.: "Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results". JAMA, 1999, 281, 1605.
2. Solomon D., Schiffman M., Tarone R.: "Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial". J. Natl. Cancer Inst., 2001, 93, 293.
3. Cox J.T., Lorincz A.T., Schiffman M.H., Sherman M.E., Cullen A., Kurman R.J.: " Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance " . Am. J. Obstet. Gynecol., 1995, 172, 946.
4. Lachman M.F., Cavallo-Calvanese C.: "Qualification of atypical squamous cells of undetermined significance in an independent laboratory: is it useful or significant?". Am. J. Obstet. Gynecol., 1998, 179, 421.
5. Williams M.L., Rimm D.L., Pedigo M.A., Frable W.J.: " Atypical squamous cells of undetermined significance: correlative histologic and follow-up studies from an academic medical center ". Diagn. Cytopathol., 1997, 16, 1.
6. Shlay J.C., Dunn T., Byers T., Baron A.E., Douglas J.M. Jr.: " Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on papanicolaou smears". Obstet. Gynecol., 2000, 96, 410.
7. Wensveen C.W.M., Kagie M.J., Veldhuizen R.W., de Groot C.J.M., Denny L., Zwinderman C. et al.: "Detection of cervical intraepithelial neoplasia in women with atypical squamous or glandular cells of undetermined significance: A prospective study". Acta Obstet. Gynecol., Scand., 2003, 82, 883.
8. Ferenczy A., Franco E.: "Persistent human papillomavirus infection and cervical neoplasia". Lancet Oncol., 2002, 3, 11.
9. Nobbenhuis M.A., Walboomers J.M., Heimerhorst T.J., Rozendaal L., Remmink A.J., Risse E.K. et al.: "Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study". Lancet, 1999, 354, 20.
10. Cuzick J., Szarewski A., Terry G., Ho L., Hanby A., Maddox P. et al.: "Human papillomavirus testing in primary cervical screening". Lancet, 1995, 345, 1533.
11. Kulasingam S.L., Hughes J.P., Kiviat N.B., Mao C., Weiss N.S., Kuypers J.M. et al.: "Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral". JAMA, 2002, 288, 1749.
12. Hatch K.D., Schneider A., Abdel-Nour M.W.: "An evaluation of human papillomavirus testing for intermediate- and high-risk types as triage before colposcopy". Am. J. Obstet. Gynecol., 1995, 172, 1150.
13. Sherman M.E., Schiffman M., Cox J.T.: "Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS)". J. Natl. Cancer Inst., 2002, 94, 102.
14. Ferris D.G., Wright T.C. Jr., Litaker M.S., Richart R.M., Lorincz A.T., Sun X.W. et al.: "Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?". J. Fam. Pract., 1998, 46, 125.
15. Ferenczy A., Franco E., Arseneau J., Wright T.C., Richart R.M.: "Diagnostic performance of Hybrid Capture human papillomavirus deoxyribonucleic acid assay combined with liquid-based cytologic study". Am. J. Obstet. Gynecol., 1996, 175, 651.
16. Hanselaar A.G.: "KOPAC-B in beeld [CD-ROM]". Nijmegen, University Medical Center 1997.
17. Vooijs G.P.: "De advisering bij afwijkende bevindingen van cytologisch onderzoek van de cervix uteri". Ned. Tijdschr. Geneeskd., 1987, 131, 1662.
18. Schiffman M., Herrero R., Hildesheim A., Sherman M.E., Bratti M., Wacholder S. et al.: "HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica". JAMA, 2000, 283, 87.
19. Chenoy R., Billingham L., Irani S., Rollason T.P., Luesley D.M., Jordan J.A.: "The effect of directed biopsy on the atypical cervical transformation zone: assessed by digital imaging colposcopy". Br. J. Obstet. Gynaecol., 1996, 103, 457.
20. Ho G.Y., Bierman R., Beardsley L., Chang C.J., Burk R.D.: "Natural history of cervicovaginal papillomavirus infection in young women". N. Engl. J. Med., 1998, 338, 423.
21. Bory J.P., Cucherousset J., Lorenzato M., Gabriel R., Quereux C., Birembaut P. et al.: "Recurrent human papillomavirus infection detected with the Hybrid Capture II assay selects women with normal cervical smears at risk for developing high grade cervical lesions: a longitudinal study of 3,091 women". Int. J. Cancer, 2002, 102, 519.
22. Franco E.L., Villa L.L., Sobrinho J.P., Prado J.M., Rousseau M.C., Desy M. et al.: "Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer". J. Infect. Dis., 1999, 180, 1415.
23. Cuzick J., Terry G., Ho L., Hollingworth T., Anderson M.: "Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia". Br. J. Cancer, 1994, 69, 167.
24. van Duin M., Snijders P.J., Schrijnemakers H.F., Voorhorst F.J., Rozendaal L., Nobbenhuis M.A. et al.: "Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance". Int. J. Cancer, 2002, 98, 590.